Browsing Over 392 Presentations

Sort By
B cells as a therapeutic opportunity Educational session

Antibody responses in the TME (ID 103)

Lecture Time
11:40 - 12:00
Speakers
  • Ziv Shulman (Rehovot, Israel)
Session Name
B cells as a therapeutic opportunity
Room
Room B
Date
Thu, Dec 8, 2022
Time
11:00 - 12:30
B cells as a therapeutic opportunity Educational session

Regulatory B cells in cancer (ID 104)

Lecture Time
12:00 - 12:20
Speakers
  • Claudia Mauri (London, United Kingdom)
Session Name
B cells as a therapeutic opportunity
Room
Room B
Date
Thu, Dec 8, 2022
Time
11:00 - 12:30
B cells as a therapeutic opportunity Educational session

Q&A (ID 21)

Lecture Time
12:20 - 12:30
Speakers
  • Tullia C. Bruno (Pittsburgh, PA, United States of America)
Session Name
B cells as a therapeutic opportunity
Room
Room B
Date
Thu, Dec 8, 2022
Time
11:00 - 12:30
B cells as a therapeutic opportunity Educational session

B cell function within tertiary lymphoid structures (ID 101)

Lecture Time
11:00 - 11:20
Speakers
  • Tullia C. Bruno (Pittsburgh, PA, United States of America)
Session Name
B cells as a therapeutic opportunity
Room
Room B
Date
Thu, Dec 8, 2022
Time
11:00 - 12:30
B cells as a therapeutic opportunity Educational session

Tertiary lymphoid structure formation in non-small cell lung cancer (ID 102)

Lecture Time
11:20 - 11:40
Speakers
  • Marie-Caroline Dieu-Nosjean (Paris, France)
Session Name
B cells as a therapeutic opportunity
Room
Room B
Date
Thu, Dec 8, 2022
Time
11:00 - 12:30
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2 Industry satellite symposium

Closing remarks and audience Q&A (ID 22)

Lecture Time
14:00 - 14:15
Speakers
  • Vincenzo Bronte (Verona, Italy)
Session Name
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2 Industry satellite symposium

Welcome and introductions (ID 336)

Lecture Time
13:15 - 13:20
Speakers
  • Vincenzo Bronte (Verona, Italy)
Session Name
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2 Industry satellite symposium

Spotlight on I-O: Chemokine signaling and its role in tumor development and I-O resistance (ID 337)

Lecture Time
13:20 - 13:30
Speakers
  • Vincenzo Bronte (Verona, Italy)
Session Name
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2 Industry satellite symposium

Caught in a NET: Reviewing IL-8, CXCR1, and CXCR2 signaling in tumor biology (ID 338)

Lecture Time
13:30 - 13:45
Speakers
  • Ignacio Melero (Pamplona, Spain)
Session Name
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2 Industry satellite symposium

Emerging data for targeting IL-8, CXCR1, and/or CXCR2 as potential treatment options in solid tumors (ID 339)

Lecture Time
13:45 - 14:00
Speakers
  • Matteo Simonelli (Milan, Italy)
Session Name
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Cancer vaccines: Promise or dead end? Controversy session

Introduction and first vote (ID 375)

Lecture Time
14:05 - 14:15
Speakers
  • Stephen P. Schoenberger (La Jolla, CA, United States of America)
Session Name
Cancer vaccines: Promise or dead end?
Room
Room A
Date
Wed, Dec 7, 2022
Time
14:05 - 15:05
Cancer vaccines: Promise or dead end? Controversy session

Promise (ID 376)

Lecture Time
14:15 - 14:35
Speakers
  • Christian H. Ottensmeier (Liverpool, United Kingdom)
Session Name
Cancer vaccines: Promise or dead end?
Room
Room A
Date
Wed, Dec 7, 2022
Time
14:05 - 15:05